In a groundbreaking study called the STEP program, participants with overweight or obesity who received Ozempic experienced significant weight reduction compared to those receiving a placebo
In the SUSTAIN program, three adjudicated events of malignant thyroid neoplasm were identified, two in semaglutide-treated patients (combined n = 5,933), and one in the comparator group (n = 4,736) ( versus one in the comparator group (83)
The Step-by-Step Protocol: How to Reconstitute 15 mg Retatrutide Now, we get to the heart of the matter
The long-term safety profile is generally reassuring
Current evidence is more supportive of using biweekly doses as a maintenance strategy only
Medical Advice: This content is for informational purposes only and does not constitute medical advice